Literature DB >> 12454918

Morphogen gradients, positional information, and Xenopus: interplay of theory and experiment.

Jeremy Green1.   

Abstract

The idea of morphogen gradients has long been an important one in developmental biology. Studies with amphibians and with Xenopus in particular have made significant contributions to demonstrating the existence, identity, and mechanisms of action of morphogens. Mesoderm induction and patterning by activin, nodals, bone morphogenetic proteins, and fibroblast growth factors have been analyzed thoroughly and reveal recurrent and combinatorial roles for these protein growth factor morphogens and their antagonists. The dynamics of nodal-type signaling and the intersection of VegT and beta-catenin intracellular gradients reveal detailed steps in early long-range patterning. Interpretation of gradients requires sophisticated mechanisms for sharpening thresholds, and the activin-Xbra-Gsc system provides an example of this. The understanding of growth factor signal transduction has elucidated growth factor morphogen action and provided tools for dissecting their direct long-range action and distribution. The physical mechanisms of morphogen gradient establishment are the focus of new interest at both the experimental and theoretical level. General themes and emerging trends in morphogen gradient studies are discussed. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454918     DOI: 10.1002/dvdy.10170

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  27 in total

1.  Computational analysis of BMP gradients in dorsal-ventral patterning of the zebrafish embryo.

Authors:  Yong-Tao Zhang; Arthur D Lander; Qing Nie
Journal:  J Theor Biol       Date:  2007-06-06       Impact factor: 2.691

Review 2.  Regulation of bone morphogenetic proteins in early embryonic development.

Authors:  Yukiyo Yamamoto; Michael Oelgeschläger
Journal:  Naturwissenschaften       Date:  2004-10-26

3.  CHD4/Mi-2beta activity is required for the positioning of the mesoderm/neuroectoderm boundary in Xenopus.

Authors:  Britta Linder; Edith Mentele; Katrin Mansperger; Tobias Straub; Elisabeth Kremmer; Ralph A W Rupp
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

4.  The competence of Xenopus blastomeres to produce neural and retinal progeny is repressed by two endo-mesoderm promoting pathways.

Authors:  Bo Yan; Sally A Moody
Journal:  Dev Biol       Date:  2007-02-07       Impact factor: 3.582

Review 5.  Morphogen gradient formation.

Authors:  Ortrud Wartlick; Anna Kicheva; Marcos González-Gaitán
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09       Impact factor: 10.005

6.  Dynamics of gene circuits shapes evolvability.

Authors:  Alba Jiménez; James Cotterell; Andreea Munteanu; James Sharpe
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

7.  Rab5-mediated endocytosis of activin is not required for gene activation or long-range signalling in Xenopus.

Authors:  Anja I Hagemann; Xin Xu; Oliver Nentwich; Marko Hyvonen; James C Smith
Journal:  Development       Date:  2009-07-15       Impact factor: 6.868

8.  Whole-genome microRNA screening identifies let-7 and mir-18 as regulators of germ layer formation during early embryogenesis.

Authors:  Alexandre R Colas; Wesley L McKeithan; Thomas J Cunningham; Paul J Bushway; Lana X Garmire; Gregg Duester; Shankar Subramaniam; Mark Mercola
Journal:  Genes Dev       Date:  2012-11-14       Impact factor: 11.361

9.  Myotubularin-related protein 4 (MTMR4) attenuates BMP/Dpp signaling by dephosphorylation of Smad proteins.

Authors:  Junjing Yu; Xiaomeng He; Ye-Guang Chen; Yan Hao; Shuo Yang; Lei Wang; Lei Pan; Hong Tang
Journal:  J Biol Chem       Date:  2012-11-13       Impact factor: 5.157

10.  Particle tracking model of electrophoretic morphogen movement reveals stochastic dynamics of embryonic gradient.

Authors:  Ying Zhang; Michael Levin
Journal:  Dev Dyn       Date:  2009-08       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.